174 related articles for article (PubMed ID: 9160689)
1. Immunolocalization of the ICE/Ced-3-family protease, CPP32 (Caspase-3), in non-Hodgkin's lymphomas, chronic lymphocytic leukemias, and reactive lymph nodes.
Krajewski S; Gascoyne RD; Zapata JM; Krajewska M; Kitada S; Chhanabhai M; Horsman D; Berean K; Piro LD; Fugier-Vivier I; Liu YJ; Wang HG; Reed JC
Blood; 1997 May; 89(10):3817-25. PubMed ID: 9160689
[TBL] [Abstract][Full Text] [Related]
2. Cysteine protease CPP32, but not Ich1-L, is expressed in germinal center B cells and their neoplastic counterparts.
Xerri L; Devilard E; Ayello C; Brousset P; Reed JC; Emile JF; Hassoun J; Parmentier S; Birg F
Hum Pathol; 1997 Aug; 28(8):912-21. PubMed ID: 9269827
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of Mcl-1 and Bcl-2 proteins in normal and neoplastic lymph nodes.
Krajewski S; Bodrug S; Gascoyne R; Berean K; Krajewska M; Reed JC
Am J Pathol; 1994 Sep; 145(3):515-25. PubMed ID: 8080035
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical analysis of in vivo patterns of expression of CPP32 (Caspase-3), a cell death protease.
Krajewska M; Wang HG; Krajewski S; Zapata JM; Shabaik A; Gascoyne R; Reed JC
Cancer Res; 1997 Apr; 57(8):1605-13. PubMed ID: 9108467
[TBL] [Abstract][Full Text] [Related]
5. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
Dorfman DM; Shahsafaei A
Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis and expression of caspases 3, 6 and 8 in malignant non-Hodgkin's lymphomas.
Soini Y; Pääkkö P
APMIS; 1999 Nov; 107(11):1043-50. PubMed ID: 10598877
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical studies of protein kinase D (PKD) 2 expression in malignant human lymphomas.
Kovalevska LM; Yurchenko OV; Shlapatska LM; Berdova GG; Mikhalap SV; Van Lint J; Sidorenko SP
Exp Oncol; 2006 Sep; 28(3):225-30. PubMed ID: 17080017
[TBL] [Abstract][Full Text] [Related]
8. alpha-Naphthyl acetate esterase activity--a cytochemical marker for T lymphocytees. Correlation with immunologic studies of normal tissues, lymphocytic leukemias, non-Hodgkin's lymphomas, Hodgkin's disease, and other lymphoproliferative disorders.
Pinkus GS; Hargreaves HK; McLeod JA; Nadler LM; Rosenthal DS; Said JW
Am J Pathol; 1979 Oct; 97(1):17-41. PubMed ID: 315166
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis of interleukin-1beta-converting enzyme/Ced-3 family protease, CPP32/Yama/Caspase-3, in Hodgkin's disease.
Chhanabhai M; Krajewski S; Krajewska M; Wang HG; Reed JC; Gascoyne RD
Blood; 1997 Sep; 90(6):2451-5. PubMed ID: 9310497
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the interleukin-1beta-converting enzyme/ced-3-family protease, caspase-3/CPP32, in Hodgkin's disease: lack of caspase-3 expression in nodular lymphocyte predominance Hodgkin's disease.
Izban KF; Wrone-Smith T; Hsi ED; Schnitzer B; Quevedo ME; Alkan S
Am J Pathol; 1999 May; 154(5):1439-47. PubMed ID: 10329597
[TBL] [Abstract][Full Text] [Related]
11. Telomerase activation in normal B lymphocytes and non-Hodgkin's lymphomas.
Norrback KF; Dahlenborg K; Carlsson R; Roos G
Blood; 1996 Jul; 88(1):222-9. PubMed ID: 8704177
[TBL] [Abstract][Full Text] [Related]
12. Frequent nuclear localization of ICAD and cytoplasmic co-expression of caspase-8 and caspase-3 in human lymphomas.
Xerri L; Palmerini F; Devilard E; Defrance T; Bouabdallah R; Hassoun J; Birg F
J Pathol; 2000 Oct; 192(2):194-202. PubMed ID: 11004695
[TBL] [Abstract][Full Text] [Related]
13. Alkaline phosphatase-positive B cell lymphomas.
Abe M; Nozawa Y; Wachi E; Tominaga K; Hojo H; Wakasa H
Eur J Haematol; 1988 Sep; 41(3):223-9. PubMed ID: 3053240
[TBL] [Abstract][Full Text] [Related]
14. Transcription factor B-cell-specific activator protein (BSAP) is differentially expressed in B cells and in subsets of B-cell lymphomas.
Krenacs L; Himmelmann AW; Quintanilla-Martinez L; Fest T; Riva A; Wellmann A; Bagdi E; Kehrl JH; Jaffe ES; Raffeld M
Blood; 1998 Aug; 92(4):1308-16. PubMed ID: 9694719
[TBL] [Abstract][Full Text] [Related]
15. Non-Hodgkin's lymphomas of primary follicle/mantle zone origin.
Weisenburger DD
Leukemia; 1991; 5 Suppl 1():26-9. PubMed ID: 1716336
[TBL] [Abstract][Full Text] [Related]
16. MUM1/IRF4 expression as a frequent event in mature lymphoid malignancies.
Tsuboi K; Iida S; Inagaki H; Kato M; Hayami Y; Hanamura I; Miura K; Harada S; Kikuchi M; Komatsu H; Banno S; Wakita A; Nakamura S; Eimoto T; Ueda R
Leukemia; 2000 Mar; 14(3):449-56. PubMed ID: 10720141
[TBL] [Abstract][Full Text] [Related]
17. [Abnormal expression of bcl-10 protein in extranodal marginal zone B cell lymphoma of mucosa-associated lymphoid tissue lymphoma type].
Li BZ; Zhou XY; Ye HT; Yang WT; Fan YZ; Lu HF; Shi DR
Zhonghua Bing Li Xue Za Zhi; 2007 Dec; 36(12):819-24. PubMed ID: 18346354
[TBL] [Abstract][Full Text] [Related]
18. Pax5 expression in non-Hodgkin's lymphomas and acute leukemias.
Zhang X; Lin Z; Kim I
J Korean Med Sci; 2003 Dec; 18(6):804-8. PubMed ID: 14676435
[TBL] [Abstract][Full Text] [Related]
19. Expression of the retinoblastoma protein in low-grade B-cell lymphoma: relationship to cyclin D1.
Zukerberg LR; Benedict WF; Arnold A; Dyson N; Harlow E; Harris NL
Blood; 1996 Jul; 88(1):268-76. PubMed ID: 8704183
[TBL] [Abstract][Full Text] [Related]
20. Expression of glucocorticoid receptors in non-neoplastic lymphoid follicles and B cell type malignant lymphomas.
Okazaki SI; Yamakawa M; Maeda K; Ohta N; Aoyagi M
J Clin Pathol; 2006 Apr; 59(4):410-6. PubMed ID: 16461807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
